TrialMultiple sclerosis (Houndmills, Basingstoke, England)2019

CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage.

Jeppe Romme Christensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.